Cargando…
Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study
Introduction: Anorexia nervosa (AN) can co-occur with hypercarotenemia, a clinical condition characterized by elevated β-carotene in plasma and skin tissue. Carotenoids have known anti-obesogenic effects in adipocyte biology. Thus, carotenoids may potentially play a retarding role in weight gain dur...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725815/ https://www.ncbi.nlm.nih.gov/pubmed/34992554 http://dx.doi.org/10.3389/fpsyt.2021.758300 |
_version_ | 1784626189339459584 |
---|---|
author | Lackner, Sonja Meier-Allard, Nathalie Mörkl, Sabrina Müller, Wolfram Fürhapter-Rieger, Alfred Mangge, Harald Zelzer, Sieglinde Holasek, Sandra |
author_facet | Lackner, Sonja Meier-Allard, Nathalie Mörkl, Sabrina Müller, Wolfram Fürhapter-Rieger, Alfred Mangge, Harald Zelzer, Sieglinde Holasek, Sandra |
author_sort | Lackner, Sonja |
collection | PubMed |
description | Introduction: Anorexia nervosa (AN) can co-occur with hypercarotenemia, a clinical condition characterized by elevated β-carotene in plasma and skin tissue. Carotenoids have known anti-obesogenic effects in adipocyte biology. Thus, carotenoids may potentially play a retarding role in weight gain during the recovery of AN patients. This study evaluated the plasma carotenoid profile and subcutaneous adipose tissue (SAT) in a cohort of AN patients and normal weight (NW) controls. Methods: Plasma concentrations of α-carotene, β-carotene, β-cryptoxanthin, and lycopene were determined by HPLC analysis. SAT thicknesses were measured by a highly accurate and reliable ultrasound technique. Information on dietary intakes were collected by repeated 24-h recalls. Results: Sixty-two females (AN: n = 18, NW: n = 44) were included. The concentrations of β-cryptoxanthin (p = 0.045) and lycopene (p = 0.004) were significantly lower in AN patients. β-carotene levels were higher in AN patients (n.s.) and α-carotene did not differ significantly. SAT thickness was significantly lower in AN patients compared to controls (p < 0.001). β-carotene was significantly negative (r(s) = −0.471) and lycopene significantly positive (r(s) = 0.366) correlated with SAT. The correlation of β-carotene and SAT was even higher in the AN group alone (r(s) = −0.742). Also, β- cryptoxanthin and the sum of provitamin A carotenoids were correlated to SAT (r(s) = −0.647 and r(s) = −0.746, respectively) in AN patients. Fruits and vegetable intake did not differ significantly between AN and NW but adjusted for SAT, AN patients consumed relatively higher amounts (p = 0.006). Conclusion: Higher plasma β-carotene concentrations were associated with reduced SAT levels, most probably due to a reduced ability of the remaining adipose tissue to store carotenoids. Thus, the antiobesity effects of carotenoids might impact the treatment success of undernutrition and AN. A systemic carotenoid overload may contribute to changes in adipogenesis and metabolic capacities for energy storage. Therefore, high plasma β-carotene may be a marker of delay in weight recovery in AN patients. Interventional studies should consider including carotenoid-status in AN treatment. |
format | Online Article Text |
id | pubmed-8725815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87258152022-01-05 Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study Lackner, Sonja Meier-Allard, Nathalie Mörkl, Sabrina Müller, Wolfram Fürhapter-Rieger, Alfred Mangge, Harald Zelzer, Sieglinde Holasek, Sandra Front Psychiatry Psychiatry Introduction: Anorexia nervosa (AN) can co-occur with hypercarotenemia, a clinical condition characterized by elevated β-carotene in plasma and skin tissue. Carotenoids have known anti-obesogenic effects in adipocyte biology. Thus, carotenoids may potentially play a retarding role in weight gain during the recovery of AN patients. This study evaluated the plasma carotenoid profile and subcutaneous adipose tissue (SAT) in a cohort of AN patients and normal weight (NW) controls. Methods: Plasma concentrations of α-carotene, β-carotene, β-cryptoxanthin, and lycopene were determined by HPLC analysis. SAT thicknesses were measured by a highly accurate and reliable ultrasound technique. Information on dietary intakes were collected by repeated 24-h recalls. Results: Sixty-two females (AN: n = 18, NW: n = 44) were included. The concentrations of β-cryptoxanthin (p = 0.045) and lycopene (p = 0.004) were significantly lower in AN patients. β-carotene levels were higher in AN patients (n.s.) and α-carotene did not differ significantly. SAT thickness was significantly lower in AN patients compared to controls (p < 0.001). β-carotene was significantly negative (r(s) = −0.471) and lycopene significantly positive (r(s) = 0.366) correlated with SAT. The correlation of β-carotene and SAT was even higher in the AN group alone (r(s) = −0.742). Also, β- cryptoxanthin and the sum of provitamin A carotenoids were correlated to SAT (r(s) = −0.647 and r(s) = −0.746, respectively) in AN patients. Fruits and vegetable intake did not differ significantly between AN and NW but adjusted for SAT, AN patients consumed relatively higher amounts (p = 0.006). Conclusion: Higher plasma β-carotene concentrations were associated with reduced SAT levels, most probably due to a reduced ability of the remaining adipose tissue to store carotenoids. Thus, the antiobesity effects of carotenoids might impact the treatment success of undernutrition and AN. A systemic carotenoid overload may contribute to changes in adipogenesis and metabolic capacities for energy storage. Therefore, high plasma β-carotene may be a marker of delay in weight recovery in AN patients. Interventional studies should consider including carotenoid-status in AN treatment. Frontiers Media S.A. 2021-12-20 /pmc/articles/PMC8725815/ /pubmed/34992554 http://dx.doi.org/10.3389/fpsyt.2021.758300 Text en Copyright © 2021 Lackner, Meier-Allard, Mörkl, Müller, Fürhapter-Rieger, Mangge, Zelzer and Holasek. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Lackner, Sonja Meier-Allard, Nathalie Mörkl, Sabrina Müller, Wolfram Fürhapter-Rieger, Alfred Mangge, Harald Zelzer, Sieglinde Holasek, Sandra Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study |
title | Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study |
title_full | Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study |
title_fullStr | Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study |
title_full_unstemmed | Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study |
title_short | Hypercarotenemia in Anorexia Nervosa Patients May Influence Weight Balance: Results of a Clinical Cross-Sectional Cohort Study |
title_sort | hypercarotenemia in anorexia nervosa patients may influence weight balance: results of a clinical cross-sectional cohort study |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725815/ https://www.ncbi.nlm.nih.gov/pubmed/34992554 http://dx.doi.org/10.3389/fpsyt.2021.758300 |
work_keys_str_mv | AT lacknersonja hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy AT meierallardnathalie hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy AT morklsabrina hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy AT mullerwolfram hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy AT furhapterriegeralfred hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy AT manggeharald hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy AT zelzersieglinde hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy AT holaseksandra hypercarotenemiainanorexianervosapatientsmayinfluenceweightbalanceresultsofaclinicalcrosssectionalcohortstudy |